ASX - By Stock
|
BCM |
Re:
Ann: Bioleaching test work continues to show excellent results
|
|
Invest Egate
|
101 |
32K |
5 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
101
|
32K
|
5
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Bioleaching test work continues to show excellent results
|
|
Invest Egate
|
101 |
32K |
8 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
101
|
32K
|
8
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Change in substantial holding
|
|
Invest Egate
|
1 |
917 |
13 |
09/01/23 |
09/01/23 |
ASX - By Stock
|
1
|
917
|
13
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Change of Director's Interest Notice - AD
|
|
Invest Egate
|
9 |
3.5K |
6 |
04/01/23 |
04/01/23 |
ASX - By Stock
|
9
|
3.5K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Bioleaching test work continues to show excellent results
|
|
Invest Egate
|
101 |
32K |
10 |
21/12/22 |
21/12/22 |
ASX - By Stock
|
101
|
32K
|
10
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Bioleaching test work continues to show excellent results
|
|
Invest Egate
|
101 |
32K |
4 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
101
|
32K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Bioleaching test work continues to show excellent results
|
|
Invest Egate
|
101 |
32K |
3 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
101
|
32K
|
3
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Bioleaching test work continues to show excellent results
|
|
Invest Egate
|
101 |
32K |
7 |
19/12/22 |
19/12/22 |
ASX - By Stock
|
101
|
32K
|
7
|
|
ASX - By Stock
|
HCD |
Re:
Ann: North Sea Purchase Order
|
|
Invest Egate
|
65 |
15K |
3 |
15/12/22 |
15/12/22 |
ASX - By Stock
|
65
|
15K
|
3
|
|
ASX - By Stock
|
HCD |
Re:
Ann: Update on Alberta, Canada Trial
|
|
Invest Egate
|
38 |
9.9K |
4 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
38
|
9.9K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
8 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
177
|
48K
|
8
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
1 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
177
|
48K
|
1
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
5 |
30/11/22 |
30/11/22 |
ASX - By Stock
|
177
|
48K
|
5
|
|
ASX - By Stock
|
AVR |
Re:
Ann: FDA Approves Early Feasibility Study for DurAVR THV System
|
|
Invest Egate
|
47 |
18K |
9 |
28/11/22 |
28/11/22 |
ASX - By Stock
|
47
|
18K
|
9
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Appointment of Chairman
|
|
Invest Egate
|
7 |
2.5K |
0 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
7
|
2.5K
|
0
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Appointment of Chairman
|
|
Invest Egate
|
7 |
2.5K |
10 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
7
|
2.5K
|
10
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Appointment of Chairman
|
|
Invest Egate
|
7 |
2.5K |
11 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
7
|
2.5K
|
11
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
6 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
177
|
48K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
10 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
177
|
48K
|
10
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
2 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
177
|
48K
|
2
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
3 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
177
|
48K
|
3
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
4 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
177
|
48K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
6 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
177
|
48K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
6 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
177
|
48K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
7 |
16/11/22 |
16/11/22 |
ASX - By Stock
|
177
|
48K
|
7
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
5
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
5
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
4 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
5 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
5
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
4 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
3 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
3
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
7 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
7
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
6 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
4 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
177
|
48K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
6 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
177
|
48K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
11 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
177
|
48K
|
11
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
11 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
177
|
48K
|
11
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Initial results from bioleaching test work
|
|
Invest Egate
|
177 |
48K |
10 |
14/11/22 |
14/11/22 |
ASX - By Stock
|
177
|
48K
|
10
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
3 |
13/11/22 |
13/11/22 |
ASX - By Stock
|
61
|
16K
|
3
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Corporate Presentation - November 2022
|
|
Invest Egate
|
23 |
6.2K |
8 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
23
|
6.2K
|
8
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Corporate Presentation - November 2022
|
|
Invest Egate
|
23 |
6.2K |
8 |
02/11/22 |
02/11/22 |
ASX - By Stock
|
23
|
6.2K
|
8
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
7 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
61
|
16K
|
7
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
2 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
61
|
16K
|
2
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
4 |
27/10/22 |
27/10/22 |
ASX - By Stock
|
61
|
16K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
11 |
26/10/22 |
26/10/22 |
ASX - By Stock
|
61
|
16K
|
11
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
2 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
61
|
16K
|
2
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
4 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
61
|
16K
|
4
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
6 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
61
|
16K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
6 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
61
|
16K
|
6
|
|
ASX - By Stock
|
BCM |
Re:
Ann: Maiden Mineral Resource at Tres Estados
|
|
Invest Egate
|
61 |
16K |
17 |
25/10/22 |
25/10/22 |
ASX - By Stock
|
61
|
16K
|
17
|
|